266 related articles for article (PubMed ID: 2476322)
1. Correlative changes of serotonin and catecholamines with pharmacokinetic alterations of imipramine in rat brain.
Sugita S; Kobayashi A; Suzuki S; Yoshida T; Nakazawa K
Eur J Pharmacol; 1989 Jun; 165(2-3):191-8. PubMed ID: 2476322
[TBL] [Abstract][Full Text] [Related]
2. Effects of lithium on alterations of pharmacokinetics of imipramine and on the related changes of monoamines in rat brain.
Yoshida T; Suzuki S; Sugita S; Kobayashi A; Nakazawa K
Eur J Pharmacol; 1989 Dec; 173(2-3):143-9. PubMed ID: 2625134
[TBL] [Abstract][Full Text] [Related]
3. Changes of serotonin and catecholamines are related to pharmacokinetic alterations of clomipramine in rat brain.
Fujita K; Kobayashi A; Suzuki S; Nakazawa K
Eur J Pharmacol; 1991 Nov; 204(3):227-33. PubMed ID: 1723048
[TBL] [Abstract][Full Text] [Related]
4. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
[TBL] [Abstract][Full Text] [Related]
5. Androgen inhibits neurotransmitter turnover in the medial prefrontal cortex of the rat following exposure to a novel environment.
Handa RJ; Hejna GM; Lorens SA
Brain Res; 1997 Mar; 751(1):131-8. PubMed ID: 9098576
[TBL] [Abstract][Full Text] [Related]
6. Triiodothyronine increases desipramine with changing the concentrations of monoamines, in the brain of rat given imipramine.
Suzuki S; Yoshida T; Sugita S; Kobayashi A; Nakazawa K
Eur J Pharmacol; 1993 Feb; 231(2):297-300. PubMed ID: 7681006
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of nomifensine on in vivo uptake and metabolism of dopamine, noradrenaline and serotonin in the rat brain.
Broch OJ
Pharmacol Toxicol; 1987 Jan; 60(1):70-4. PubMed ID: 3562394
[TBL] [Abstract][Full Text] [Related]
8. Cocaine and regional brain monoamines in mice.
Hadfield MG; Milio C
Pharmacol Biochem Behav; 1992 Oct; 43(2):395-403. PubMed ID: 1438479
[TBL] [Abstract][Full Text] [Related]
9. Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function.
Singer S; Rossi S; Verzosa S; Hashim A; Lonow R; Cooper T; Sershen H; Lajtha A
Neurochem Res; 2004 Sep; 29(9):1779-92. PubMed ID: 15453274
[TBL] [Abstract][Full Text] [Related]
10. The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: a comparison with peripheral changes.
Karoum F; Korpi ER; Chuang LW; Linnoila M; Wyatt RJ
Eur J Pharmacol; 1986 Mar; 121(3):377-85. PubMed ID: 2422047
[TBL] [Abstract][Full Text] [Related]
11. [Effect of fluvoxamine, a new antidepressant drug, on monoamine dynamics in the rat cerebral limbic system and its pharmacological characteristic].
Baba T; Takeda H; Lee JW; Takada K; Shibuya T
Nihon Yakurigaku Zasshi; 1995 Mar; 105(3):177-85. PubMed ID: 7536700
[TBL] [Abstract][Full Text] [Related]
12. Region-specific decrease of dopamine and its metabolites in brains of mice given ergotamine.
Filipov NM; Thompson FN; Tsunoda M; Sharma RP
J Toxicol Environ Health A; 1999 Jan; 56(1):47-58. PubMed ID: 9923753
[TBL] [Abstract][Full Text] [Related]
13. Pineal melatonin and brain transmitter monoamines in CBA mice during chronic oral nicotine administration.
Gäddnäs H; Pietilä K; Alila-Johansson A; Ahtee L
Brain Res; 2002 Dec; 957(1):76-83. PubMed ID: 12443982
[TBL] [Abstract][Full Text] [Related]
14. Methyl bromide alters catecholamine and metabolite concentrations in rat brain.
Honma T; Miyagawa M; Sato M
Neurotoxicol Teratol; 1987; 9(5):369-75. PubMed ID: 2447477
[TBL] [Abstract][Full Text] [Related]
15. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases.
Irifune M; Fukuda T; Nomoto M; Sato T; Kamata Y; Nishikawa T; Mietani W; Yokoyama K; Sugiyama K; Kawahara M
Brain Res; 1997 Jul; 763(2):281-4. PubMed ID: 9296573
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome.
Legangneux E; Mora JJ; Spreux-Varoquaux O; Thorin I; Herrou M; Alvado G; Gomeni C
Rheumatology (Oxford); 2001 Mar; 40(3):290-6. PubMed ID: 11285376
[TBL] [Abstract][Full Text] [Related]
17. Effect of methylmercury exposure on different neurotransmitter systems in rat brain.
Tsuzuki Y
Toxicol Lett; 1982 Oct; 13(3-4):159-62. PubMed ID: 6183792
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.
Dunn AJ; Berridge CW
Pharmacol Biochem Behav; 1987 Aug; 27(4):685-91. PubMed ID: 2443934
[TBL] [Abstract][Full Text] [Related]
19. Effects of neuropeptide Y on norepinephrine and serotonin metabolism in rat hypothalamus in vivo.
Shimizu H; Bray GA
Brain Res Bull; 1989 Jun; 22(6):945-50. PubMed ID: 2477116
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Sirinathsinghji DJ; Whittington PE; Audsley AR
Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
